The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

The Honoring Our Fallen Heroes Act is considered crucial by its supporters, with climate change fueling an increase in wildfire frequency and firefighting deemed carcinogenic by the World Health ...

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They e ...

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as first-line treatment for adults with unresectable or metastatic HCC.

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

Data suggest that taletrectinib “provides clinically meaningful tumor shrinkage and prolonged disease control as a treatment option for advanced ROS1+ NSCLC, regardless of treatment history,” ...

BeiGene has decided to end the clinical development program for ociperlimab (BGB-A1217) as a treatment for lung cancer.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The Trump administration is attempting to slash NIH funding, terminate research grants, and reduce the agency’s workforce.

(HealthDay News) — Weeks after ordering staff back to the office, the US Food and Drug Administration (FDA) is letting some employees work from home again, The Associated Press reported. The move ...

Some recent cuts at government health agencies may be reversed, including a key program that tracks lead exposure in children, the HHS secretary said last week.